These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16762630)

  • 1. HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis.
    Shin SM; Chung YJ; Oh ST; Jeon HM; Hwang LJ; Namkoong H; Kim HK; Cho GW; Hur SY; Kim TE; Lee YS; Park YG; Ko J; Kim JW
    Gastroenterology; 2006 Jun; 130(7):2074-86. PubMed ID: 16762630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.
    Ko J; Lee YH; Hwang SY; Lee YS; Shin SM; Hwang JH; Kim J; Kim YW; Jang SW; Ryoo ZY; Kim IK; Namkoong SE; Kim JW
    Oncogene; 2003 Jul; 22(30):4679-89. PubMed ID: 12879013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression.
    Cho GW; Shin SM; Namkoong H; Kim HK; Ha SA; Hur SY; Kim TE; Chai YG; Kim JW
    Gene; 2006 Dec; 384():18-26. PubMed ID: 16949218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
    Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
    Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HCCR oncoprotein as a biomarker for human breast cancer.
    Jung SS; Park HS; Lee IJ; Namkoong H; Shin SM; Cho GW; Ha SA; Park YG; Lee YS; Ko J; Kim JW
    Clin Cancer Res; 2005 Nov; 11(21):7700-8. PubMed ID: 16278390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice.
    Ko J; Shin SM; Oh YM; Lee YS; Ryoo ZY; Lee YH; Na DS; Kim JW
    Oncogene; 2004 Mar; 23(10):1950-3. PubMed ID: 14691448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCCRBP-3 induces tumorigenesis through direct interaction with HCCR-1 in human cancers.
    Ha SA; Kim HK; Yoo JA; Kim S; Shin SM; Gong GH; Lee YK; Kim JW
    Mol Carcinog; 2014 Jan; 53(1):30-7. PubMed ID: 22851403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCCRBP-1 directly interacting with HCCR-1 induces tumorigenesis through P53 stabilization.
    Ha SA; Shin SM; Lee YJ; Kim S; Kim HK; Namkoong H; Lee H; Lee YS; Cho YS; Park YG; Jeon HM; Oh C; Kim JW
    Int J Cancer; 2008 Feb; 122(3):501-8. PubMed ID: 17943721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1.
    Ruan WJ; Lin J; Xu EP; Xu FY; Ma Y; Deng H; Huang Q; Lv BJ; Hu H; Cui J; Di MJ; Dong JK; Lai MD
    J Zhejiang Univ Sci B; 2006 Nov; 7(11):929-32. PubMed ID: 17048309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
    Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
    Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
    Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
    Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis.
    Sagiv E; Memeo L; Karin A; Kazanov D; Jacob-Hirsch J; Mansukhani M; Rechavi G; Hibshoosh H; Arber N
    Gastroenterology; 2006 Aug; 131(2):630-9. PubMed ID: 16890615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sp1 is involved in H2O2-induced PUMA gene expression and apoptosis in colorectal cancer cells.
    Wang X; Wang J; Lin S; Geng Y; Wang J; Jiang B
    J Exp Clin Cancer Res; 2008 Sep; 27(1):44. PubMed ID: 18811981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.
    Ohta M; Seto M; Ijichi H; Miyabayashi K; Kudo Y; Mohri D; Asaoka Y; Tada M; Tanaka Y; Ikenoue T; Kanai F; Kawabe T; Omata M
    Gastroenterology; 2009 Jan; 136(1):206-16. PubMed ID: 18992247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization.
    Kim MY; Yim SH; Kwon MS; Kim TM; Shin SH; Kang HM; Lee C; Chung YJ
    Gastroenterology; 2006 Dec; 131(6):1913-24. PubMed ID: 17087931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.